Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1Gastrointestinal 1

Conditions

Sarcoma 1Prostatic Neoplasms 1Osteosarcoma 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1

Interventions

Specimen Handling 280Magnetic Resonance Spectroscopy 233pembrolizumab 220Carboplatin 180Cisplatin 146Biopsy 146Cyclophosphamide 138Paclitaxel 128Nivolumab 118Bevacizumab 106Gemcitabine 105Radiotherapy 90Dexamethasone 83Pemetrexed 79fludarabine 74Docetaxel 74atezolizumab 73Fluorouracil 73Doxorubicin 73Radiation 72Leucovorin 68Rituximab 66Oxaliplatin 64venetoclax 60Prednisone 60durvalumab 58Cetuximab 56Vincristine 55Etoposide 54Lenalidomide 53

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Pafolacianine × 30 days × Clear all
NCT06235125 2026-06-05

Cytalux

Ann & Robert H Lurie Children's Hospital of Chicago

Phase 1 Recruiting
10 enrolled
Sarcoma

Sarcoma, Osteosarcoma

NCT07039526 2026-06-05

Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer.

University of Texas Southwestern Medical Center

Phase 2 Recruiting
50 enrolled
Gastrointestinal

Esophageal Neoplasms, Gastrointestinal Neoplasms

NCT06434909 2026-06-01

CYTALUXâ„¢for the Intraoperative Imaging of Prostate Cancer

Indiana University

Phase 2 Completed
9 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡